Story perspectives

Pharma Lobbying Intensifies Against Kennedy's Vaccine Approval Changes

9/3/2025

42 10

Summary

Story summary

HHS Secretary Robert F. Kennedy Jr. seeks to end emergency use authorizations and tighten vaccine approval processes, raising concerns for pharmaceutical companies.
The Biotechnology Innovation Organization (BIO) convened secretly to develop lobbying strategies against Kennedy's initiatives.
A leaked document indicates BIO intends to allocate $2 million for a vaccine messaging campaign in Washington, D.C., employing persuasive tactics to influence public opinion.

1 of 1

Story summary

HHS Secretary Robert F. Kennedy Jr. seeks to end emergency use authorizations and tighten vaccine approval processes, raising concerns for pharmaceutical companies.
The Biotechnology Innovation Organization (BIO) convened secretly to develop lobbying strategies against Kennedy's initiatives.
A leaked document indicates BIO intends to allocate $2 million for a vaccine messaging campaign in Washington, D.C., employing persuasive tactics to influence public opinion.